Executive Summary
Act III of COVID: Navigating the Crosscurrents of Post-Inflation
2022 ushered in Act III of the market’s latest transitionary period: The Post-Inflation Era. Since 2008, the US economy functioned with remarkably low inflation and interest rates. As the cost of capital went lower and lower during the decade, valuations steadily rose. Between 2010 and 2020, the NASDAQ experienced a 17.1% annual growth rate, with no small share of the growth a result of expanding valuation
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
Cleerly Raises $192M for AI-Driven Precision Heart Health Platform
What You Should Know:
- Cleerly, the company creating a new standard of care for heart disease, announced that it has closed a Series C financing round of $192M
- This new funding, led by led by funds and accounts advised by T. Rowe Price Associates, Inc. and T. Rowe Price Investment Management, Inc., and Fidelity Management and Research Company, brings the total raised by the fast-growing health care company to $248M, which includes its Series B round in 2021
AI-enabled Approach
Read More
Medable Partners with Withings Health Solutions to Integrate Health Devices in Decentralized Clinical Trials
What You Should Know:
- Medable Inc., the leading SaaS platform provider for patient-centered clinical trials, today announced a new partnership with Withings Health Solutions, the business-to-business division of Withings, one of the global leaders in at-home connected health
- Withings’ devices will seamlessly connect to Medable’s decentralized clinical trial platform, reducing the burden on sponsors and sites while empowering patients to participate in trials from home.
Read More
ForSight Robotics Raises $55M to Develop Robotic Cataract Surgery Procedure
What You Should Know:
- Israeli-based ForSight Robotics, the pioneer in ophthalmic robotic surgery raises $55M in Series A funding to advance the world’s first surgical platform for fully robotic cataract surgery: ORYOM. The round was led by The Adani Group with existing investors Eclipse Ventures and Mithril Capital. A number of new investors, including Provenio Capital, Precision Capital, Reiya Ventures, the Ljungstrom family office, and other prominent private investors also joined the
Read More
Practicing for the Next Pandemic with Real-World Data
Data reporting challenges during the current pandemic relate to the lack of connectivity between public health and information technology (IT) reporting systems throughout the country. While access to real-world data (RWD) helps address this situation, the solution goes beyond simple accessibility.
Real-world data represents data collected outside of randomized clinical trials, such as patient data from electronic health records (EHRs), mobile and smart devices, claims and billing activity
Read More
Wysa Secures $20M for AI-Powered Mental Health Chatbot
What You Should Know:
- Wysa, a Boston, MA-based AI digital platform for mental health, today announces it has secured $20M in financing led by HealthQuad, who along with British International Investment (BII), the UK’s development finance institution, joins earlier investors W Health Ventures, Kae Capital, Google Assistant Investments, and pi Ventures amongst others.
- Funds will enable access to clinically evidenced digital therapeutics (DTx) in the US, UK, India and other global
Read More
Care Access Acquires IBPClin to Expand Decentralized Clinical Trial Capabilities to Latin America
What You Should Know:
- Today, Care Access announced the acquisition of IBPClin, a leading clinical trial center in Rio de Janeiro. As a result, Care Access will bring its innovative approach to decentralized clinical research to Latin America.
- The acquisition demonstrates progress toward building diverse representation in clinical research and is a strategic first step following Reify Health’s $220 million investment
Read More
Reimagining The Future of Pharmacovigilance (PV): Regulations, Tech, Public Perceptions
Monitoring the safe and effective use of medicines has now been an essential part of public health policy for several decades. New advances in technology (e.g., ICH E2B for the electronic exchange of case reports) over the past 20 years coupled with progressive legislation have been a catalyst for an explosion in safety data over this period.
Since the World Health Organization (WHO) declared the Covid-19 pandemic in March 2020, the rate of reporting of safety data has been unprecedented
Read More
Analysis: Is Oracle Cerner Planning to Build A National EHR?
Earlier this month Oracle closed its $28.3B acquisition of Cerner and shortly after Oracle founder and CTO, Larry Ellison, outlined Oracle’s vision for Healthcare IT post-acquisition. The key elements of this vision included:
- Developing a solution for a national EHR database.
- Leveraging this solution, and similar smaller-scale connected EHR initiatives, to provide life science, pharma and other users with a rich environment for research, clinical trials and drug
Read More
Walgreens Launches New Clinical Trial Business to Address Access & Diversity
What You Should Know:
- Walgreens today announced the launch of its clinical trial business to redefine the patient experience and increase access and retention in sponsor-led drug development research.
- Walgreens flexible clinical trial model combines the company’s vast foundation of patient insights, partner-enabled health and technology capabilities and in-person and virtual care options to break through barriers to engaging broader and more diverse communities.
Patient Recruitment
Read More
